Dr. Jacob Lalezari Quest Clinical Research, USA

Jacob P. Lalezari, M.D., is the Medical Director of Quest Clinical Research in San Francisco, California, and interim Chief Medical Officer of CytoDyn, providing leadership for the COVID-19 Leronlimab clinical trials. Since 1989, Dr. Lalezari has been a Principal Investigator for all phases of clinical trials testing new antiviral therapies... read moreand/or vaccines for HIV/AIDS, Cytomegalovirus, Herpes Simplex Virus, Hepatitis B & C, Human Papilloma Virus, Respiratory Syncytial Virus, Influenza Virus and SARS-CoV-2.

Dr. Lalezari’s work has been published in peer-reviewed journals such as New England Journal of Medicine, Journal of Infectious Diseases and Annals of Internal Medicine. He received his M.D. in Internal Medicine from the University of Pennsylvania and holds a M.A. in English Literature from the University of Virginia.